Results 221 to 230 of about 1,516,429 (359)

Use of semaglutide and risk of non‐arteritic anterior ischemic optic neuropathy: A Danish–Norwegian cohort study

open access: yesDiabetes, Obesity and Metabolism, Volume 27, Issue 6, Page 3094-3103, June 2025.
Abstract Aims To investigate the putative association between semaglutide and non‐arteritic anterior ischaemic optic neuropathy (NAION). Materials and Methods Data from national health registries in Denmark (2018–2024) and Norway (2018–2022) were used to compare NAION risk in individuals with type 2 diabetes initiating semaglutide versus sodium‐glucose
Emma Simonsen   +9 more
wiley   +1 more source

Quantifying burden of intravitreal injections: questionnaire assessment of life impact of treatment by intravitreal injections (QUALITII). [PDF]

open access: yesBMJ Open Ophthalmol, 2022
Wang R   +18 more
europepmc   +1 more source

Bacterial endophthalmitis following anti-VEGF intravitreal injections: a retrospective case series. [PDF]

open access: yesInt J Retina Vitreous, 2023
Bergamo VC   +5 more
europepmc   +1 more source

2018 Update on Intravitreal Injections: Euretina Expert Consensus Recommendations

open access: yesOphthalmologica, 2018
A. Grzybowski   +6 more
semanticscholar   +1 more source

Prognostic factors for visual acuity improvement after intravitreal triamcinolone injection [PDF]

open access: bronze, 2006
Shiri Shulman   +4 more
openalex   +1 more source

Intravitreal Injections and Face Masks: Endophthalmitis Risk Before and During the COVID-19 Pandemic. [PDF]

open access: yesJ Ophthalmic Vis Res, 2023
Karimi S   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy